News

The blinded pivotal trial, which will serve as the basis for the company’s pre-market approval (PMA) application with the FDA, was conducted at seven centers in the US.

According to the company, Cleviprex, a novel intravenous antihypertensive, represents an advancement over currently available therapies, providing rapid and precise control of blood pressure in the critical care

Astrea has committed to purchase one StemSource cell bank for Singapore following receipt of regulatory clearance in Singapore on a pending application on the use of the Celution

The acquisition is said to expand IPC’s presence into the major population centers of Southeast Florida with a network of independent physicians, who perform hospitalist services on a

Under the Independent Drug Education and Outreach Act (IDEA) of 2008, new programs will be established to train pharmacists, nurses and other health care professionals about the relative

The acquisition will be funded through a convertible debt investment of up to $25 million by an investment fund managed by Perseus. The proposed acquisition and investment are

The federal agents acted after the US attorney Catherine Hanaway filed a civil forfeiture suit and obtained a warrant to seize the unapproved new drug products being made

The analysis showed a high rate of sustained virologic response (SVR) in patients receiving boceprevir-based combination therapy in this study of 595 treatment-naive patients with chronic hepatitis C

This randomized, double-blind, placebo-controlled trial is being conducted in HIV infected patients with the potential to offer an important drug free break in their current antiretroviral therapy. The